NAPO PHARMACEUTICALS INC — Form D
NAPO PHARMACEUTICALS INC of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-10-27. The offering totals $8.9M, of which $3.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-10-27
- Form: D
- Accession: 0001188290-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $8.9M
- Amount sold: $3.4M
- Remaining: $5.5M
- Investors: 10
- Date of first sale: 2010-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-149630
Issuer
- Name: NAPO PHARMACEUTICALS INC
- CIK: 0001188290
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 185 BERRY STREET, SUITE 1300, SAN FRANCISCO, CA, 94107
- Phone: 415-371-8300
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Pravin Chaturvedi | Executive Officer | San Francisco, CA |
| Lisa Conte | Director | San Francisco, CA |
| Lisa Conte | Executive Officer | San Francisco, CA |
| Steven King | Executive Officer | AGOURA HILLS, CA |
| Dennis Fenton | Director | Camarillo, CA |
| Gregory Stock | Director | Boise, ID |
| Joshua Mailman | Director | New York, NY |
| Richard Fields | Director | New York, NY |
| Charles Thompson | Executive Officer | Boston, MA |
| Thomas Van Dyck | Director | San Francisco, CA |
| Pravi Chaturvedi | Executive Officer | San Francisco, CA |
| Sir William Young | Director | San Francisco, CA |
| Jack Van Hulst | Director | San Francisco, CA |
Other filings by this issuer (4)
More